Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Patients Factors & Impacts

Myeloma Facts

What is your experience with Dupixent in your practice?

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Hear from an expert on Identifying Patients who are appropriate candidates for Biologic treatment

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

There is significant unmet need in the management of PN¹

Look beyond the symptoms to identify and manage Patients with Type 2 Inflammation

What gives you confidence that Dupixent improves patients’ quality of life?